Early administration of dapagliflozin preserves pancreatic β-cell mass through a legacy effect in a mouse model of type 2 diabetes.
Ayumi KannoShun-Ichiro AsaharaMao KawamuraAyuko FurubayashiShoko TsuchiyaEmi SuzukiTomoko TakaiMaki Koyanagi-KimuraTomokazu MatsudaYuko OkadaWataru OgawaYoshiaki KidoPublished in: Journal of diabetes investigation (2018)
We expect that the early administration of dapagliflozin would provide a long-lasting effect in preserving pancreatic β-cell mass.